STOCK TITAN

Director Augustine Lawlor details option holdings in PRF Technologies (PRFX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

PRF Technologies Ltd. director Augustine Lawlor reported his initial holdings of stock options linked to the company’s ordinary shares. These are compensation awards rather than open-market trades.

One option covers 50 ordinary shares at an exercise price of 5,400 per share, expiring on February 23, 2031, and is fully vested from a February 23, 2021 grant under the 2019 PainReform Option Plan. A second option covers 183 ordinary shares at an exercise price of 30 per share, expiring on July 18, 2034. Of this grant, 160 options were vested on the appointment date, and the remaining 23 are scheduled to vest in two quarterly installments on April 18, 2026 and July 18, 2026, contingent on continued service.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
LAWLOR AUGUSTINE

(Last)(First)(Middle)
C/O PRF TECHNOLOGIES LTD.
65 YIGAL ALON ST.

(Street)
TEL AVIV6744316

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
PRF Technologies Ltd. [ PRFX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)(1) (2)02/23/2031Ordinary Shares50$5,400D
Employee Stock Option (Right to Buy)(1) (3)07/18/2034Ordinary Shares183$30D
Explanation of Responses:
1. Options granted under the 2019 PainReform Option Plan.
2. The grant date of this grant is February 23, 2021. This option grant is fully vested as of this date.
3. The grant date of this grant is July 18, 2024. 160 of the options were vested as of the date of appointment. The remaining 23 options will vest in two quarterly installments occurring on April 18, 2026 and July 18, 2026, subject to the Reporting Person's continued service to the Issuer as of each vesting date.
/s/ Augustine Lawlor03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

Who is the reporting insider in PRF Technologies (PRFX) latest Form 3?

The reporting person is Augustine Lawlor, who serves as a director of PRF Technologies Ltd. The Form 3 outlines his initial beneficial ownership in the company through stock option awards, rather than disclosing any open-market share purchases or sales.

What stock options does Augustine Lawlor hold in PRF Technologies (PRFX)?

Augustine Lawlor holds two Employee Stock Option positions over PRF Technologies ordinary shares, covering 50 shares at an exercise price of 5,400 and 183 shares at an exercise price of 30. Both positions are reported as directly owned derivative securities.

When do Augustine Lawlor’s PRF Technologies (PRFX) options expire?

Lawlor’s options have two different expiration dates. The 50-share option at an exercise price of 5,400 expires on February 23, 2031. The 183-share option at an exercise price of 30 expires on July 18, 2034, providing long-dated equity exposure.

How are Augustine Lawlor’s PRF Technologies (PRFX) options vesting?

The 50-share option grant is fully vested as of February 23, 2021. For the 183-share grant, 160 options were vested at appointment, while 23 options vest in two quarterly installments on April 18, 2026 and July 18, 2026, subject to continued service.

Under which plan were Augustine Lawlor’s PRF Technologies (PRFX) options granted?

Both reported option positions were granted under the 2019 PainReform Option Plan. The Form 3 footnotes specify that these equity awards are part of the company’s option plan framework, reflecting standard director or service-based compensation arrangements.

Does the PRF Technologies (PRFX) Form 3 show any insider share purchases or sales?

No, the Form 3 lists holdings of employee stock options only and shows no open-market purchases or sales. Transaction summaries indicate holding entries with unknown transaction codes, highlighting that this filing is an initial ownership statement, not a trading report.
PRF Technologies Ltd.

NASDAQ:PRFX

View PRFX Stock Overview

PRFX Rankings

PRFX Latest News

PRFX Latest SEC Filings

PRFX Stock Data

1.72M
742.49k
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv-Yafo